TITLE

Centenary of Lewy bodies (1912-2012)

AUTHOR(S)
Holdorff, Bernd; Rodrigues e Silva, Antonio; Dodel, Richard
PUB. DATE
April 2013
SOURCE
Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p509
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
During the years from 1908 until 1923, Lewy was the first to detail the pathological anatomy of Parkinson's disease, leading to his seminal contribution in 1912 describing the neuronal eosinophilic cytoplasmatic concentric inclusion bodies in the brainstem, later accomplished by more systematic investigations in 1923 (Lewy in Lewandowsky's Handbuch der Neurologie, 3. Band: Spez. Neurologie II. Springer, Berlin, pp 920-933, ). With the exception of a minority of cases and those that displayed postencephalitic Parkinsonism, Lewy was not able to confirm the significance of the substantia nigra. The findings of Tretiakoff in 1919 (significance of the substantia nigra in PD and coining of the term 'Corps de Lewy') have been underestimated or ignored for a long time. In a historical review on basal ganglia diseases from 1942, Lewy stressed the histological abnormalities of the basal ganglia and their diffuse distribution but not expressly the inclusion bodies, which in his former studies were unique in PD. For Lewy this finding was not a characteristic of the disease. Subsequent to his expulsion from Nazi-Germany in 1933, Lewy never resumed his research on PD. At the time of Lewy's death in 1950, the era of the Lewy bodies, Lewy-body-disease and the identification of atypical Parkinson syndrome cases had not even begun and followed much later.
ACCESSION #
86418920

 

Related Articles

  • Mild cognitive impairment in Parkinson's disease. Korczyn, Amos // Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p517 

    Parkinson's disease (PD) has initially been described as a clinical syndrome, although its exact definition has changed over the past centuries. The identification of the pathological changes added another level of complexity, with Lewy bodies, synuclein deposits and neuronal loss in the...

  • Regional interplay for temporal processing in Parkinson's disease: Possibilities and challenges. Schwartze, Michael; Kotz, Sonja A. // Frontiers in Neurology;Dec2015, Vol. 6, p1 

    Parkinson's disease (PD) is primarily associated with two dominant features: cardinal motor symptoms and the loss of cells in the substantia nigra pars compacta of the basal ganglia. Consequently, these aspects are major foci in PD-related research. However, PD is a neurodegenerative disease,...

  • Synphilin-1 isoforms in Parkinson’s disease: regulation by phosphorylation and ubiquitylation. Szargel, R.; Rott, R.; Engelender, S. // Cellular & Molecular Life Sciences;Jan2008, Vol. 65 Issue 1, p80 

    Parkinson’s disease (PD) is characterized by the death of dopaminergic neurons and the presence of Lewy bodies in the substantia nigra pars compacta. The mechanisms involved in the death of neurons as well as the role of Lewy bodies in the pathogenesis of the disease are still unclear....

  • Synucleins and their relationship to Parkinson’s disease. Bohlen und Halbach, Oliver // Cell & Tissue Research;Oct2004, Vol. 318 Issue 1, p163 

    Parkinson’s disease (PD) is one of the most common neurodegenerative motor disorders, marked by chronic progressive loss of neurons in the substantia nigra. It has long been believed that PD is caused by environmental factors. The discovery of genetic factors involved in PD has improved...

  • Altered expression patterns of inflammation-associated and trophic molecules in substantia nigra and striatum brain samples from Parkinson's disease, incidental Lewy body disease and normal control cases. Walker, Douglas G.; Lih-Fen Lue; Serrano, Geidy; Beach, Thomas G.; Sue, Lucia; Adler, Charles H.; Caviness, John // Frontiers in Neuroscience;Dec2015, preceding p1 

    Evidence of inflammation has been consistently associated with pathology in Parkinson's disease (PD)-affected brains, and has been suggested as a causative factor. Dopaminergic neurons in the substantia nigra (SN) pars compacta, whose loss results in the clinical symptoms associated with PD, are...

  • Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia. Ciesielska, Agnieszka; Mittermeyer, Gabriele; Hadaczek, Piotr; Kells, Adrian P; Forsayeth, John; Bankiewicz, Krystof S // Molecular Therapy;May2011, Vol. 19 Issue 5, p922 

    We elucidated the effects of parkinsonian degeneration on trafficking of AAV2-GDNF in the nigro-striatum (nigro-ST) of unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rats. Vector infused into striatum (ST) was transported to substantia nigra (SN), both pars compacta (SNc), and pars reticulata...

  • Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease. Scherfler, Christoph; Esterhammer, Regina; Nocker, Michael; Mahlknecht, Philipp; Stockner, Heike; Warwitz, Boris; Spielberger, Sabine; Pinter, Bernadette; Donnemiller, Eveline; Decristoforo, Clemens; Virgolini, Irene; Schocke, Michael; Poewe, Werner; Seppi, Klaus // Brain: A Journal of Neurology;Oct2013, Vol. 136 Issue 10, p3028 

    Signal abnormalities of the substantia nigra and the olfactory tract detected either by diffusion tensor imaging, including measurements of mean diffusivity, a parameter of brain tissue integrity, and fractional anisotropy, a parameter of neuronal fibre integrity, or transcranial sonography,...

  • A deadly spread: cellular mechanisms of α-synuclein transfer. Steiner, J. A.; Angot, E.; Brundin, P. // Cell Death & Differentiation;Sep2011, Vol. 18 Issue 9, p1425 

    Classically, Parkinson's disease (PD) is linked to dopamine neuron death in the substantia nigra pars compacta. Intracytoplasmic protein inclusions named Lewy bodies, and corresponding Lewy neurites found in neuronal processes, are also key features of the degenerative process in the substantia...

  • DJ-1 Modulates α-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70. Batelli, Sara; Albani, Diego; Rametta, Raffaela; Polito, Letizia; Prato, Francesca; Pesaresi, Marzia; Negro, Alessandro; Forloni, Gianluigi // PLoS ONE;2008, Vol. 3 Issue 4, p1 

    Background: Parkinson's disease (PD) is a neurodegenerative pathology whose molecular etiopathogenesis is not known. Novel contributions have come from familial forms of PD caused by alterations in genes with apparently unrelated physiological functions. The gene coding for alpha-synuclein...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics